Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Biffoni

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Plos One|October 12, 2012
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialGiovanni Sette, Valentina Salvati, Lorenzo Memeo, et al.
Gynecologic Oncology|February 13, 2007
A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cellsEleonora Petrucci, Luca Pasquini, Alessia Petronelli, et al.
Nature Cell Biology|June 24, 2008
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesisCatherine Labbaye, Isabella Spinello, Maria Teresa Quaranta, et al.
NMR in Biomedicine|October 22, 2013
1H NMR detects different metabolic profiles in glioblastoma stem-like cellsLaura Guidoni, Lucia Ricci-Vitiani, Antonella Rosi, et al.
International Journal of Molecular Sciences|July 26, 2020
Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon IonsAlessandra Palma, Sveva Grande, Lucia Ricci-Vitiani, et al.
Cancer Letters|April 15, 2009
High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-ImidazolideAlessia Petronelli, Ernestina Saulle, Luca Pasquini, et al.
Molecular Oncology|May 23, 2019
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanomaFrancesca Pedini, Gabriele De Luca, Federica Felicetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cellsAurelia Rughetti, Ilenia Pellicciotta, Mauro Biffoni, et al.
Neuro-Oncology|February 17, 2017
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment responseQuintino Giorgio D'Alessandris, Mauro Biffoni, Maurizio Martini, et al.
Oncotarget|October 6, 2015
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewalValentina Lulli, Mariachiara Buccarelli, Maurizio Martini, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Plos One|October 12, 2012
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialGiovanni Sette, Valentina Salvati, Lorenzo Memeo, et al.
Gynecologic Oncology|February 13, 2007
A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cellsEleonora Petrucci, Luca Pasquini, Alessia Petronelli, et al.
Nature Cell Biology|June 24, 2008
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesisCatherine Labbaye, Isabella Spinello, Maria Teresa Quaranta, et al.
NMR in Biomedicine|October 22, 2013
1H NMR detects different metabolic profiles in glioblastoma stem-like cellsLaura Guidoni, Lucia Ricci-Vitiani, Antonella Rosi, et al.
International Journal of Molecular Sciences|July 26, 2020
Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon IonsAlessandra Palma, Sveva Grande, Lucia Ricci-Vitiani, et al.
Cancer Letters|April 15, 2009
High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-ImidazolideAlessia Petronelli, Ernestina Saulle, Luca Pasquini, et al.
Molecular Oncology|May 23, 2019
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanomaFrancesca Pedini, Gabriele De Luca, Federica Felicetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cellsAurelia Rughetti, Ilenia Pellicciotta, Mauro Biffoni, et al.
Neuro-Oncology|February 17, 2017
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment responseQuintino Giorgio D'Alessandris, Mauro Biffoni, Maurizio Martini, et al.
Oncotarget|October 6, 2015
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewalValentina Lulli, Mariachiara Buccarelli, Maurizio Martini, et al.
Pageof 10